Back
Day Range
$33.03
$34.87
52-Week Range
$20.85
$54.85
Volume
634,468
50D / 200D Avg
$44.58
/
$40.45
Prev Close
$33.28
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -246.3 | 0.4 |
| P/B | 24.1 | 2.9 |
| ROE % | -8.4 | 3.8 |
| Net Margin % | -1.9 | 3.9 |
| Rev Growth 5Y % | 39.2 | 10.0 |
| D/E | 4.8 | 0.2 |
Analyst Price Target
Hold
$74.25
+118.4%
Low: $63.00
High: $94.00
Forward P/E
46.7
Forward EPS
$0.73
EPS Growth (est.)
+0.0%
Est. Revenue
370 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$8.79
$8.13 – $9.96
|
1.1 B | 1 |
| FY2029 |
$7.31
$6.76 – $8.28
|
970 M | 1 |
| FY2028 |
$4.13
$2.92 – $5.34
|
740 M | 2 |
Key Takeaways
Revenue grew 39.22% annually over 5 years — strong growth
Debt/Equity of 4.80 — high leverage
Generating 42.98M in free cash flow
Capital efficient — spends only 0.33% of revenue on capex
Interest coverage of 1.51× — tight debt servicing
Growth
Revenue Growth (5Y)
39.22%
Revenue (1Y)36.41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-8.42%
ROIC8.97%
Net Margin-1.89%
Op. Margin13.37%
Safety
Debt / Equity
4.80
Current Ratio2.20
Interest Coverage1.51
Valuation
P/E Ratio
-246.31
P/B Ratio24.14
EV/EBITDA39.69
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.41% | Revenue Growth (3Y) | 44.62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 39.22% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 272.30M | Net Income (TTM) | -5.14M |
| ROE | -8.42% | ROA | -1.29% |
| Gross Margin | 75.05% | Operating Margin | 13.37% |
| Net Margin | -1.89% | Free Cash Flow (TTM) | 42.98M |
| ROIC | 8.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4.80 | Current Ratio | 2.20 |
| Interest Coverage | 1.51 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -246.31 | P/B Ratio | 24.14 |
| P/S Ratio | 4.65 | PEG Ratio | 4.91 |
| EV/EBITDA | 39.69 | Dividend Yield | 0.00% |
| Market Cap | 1.27B | Enterprise Value | 1.44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 272.30M | 199.61M | 130.19M | 88.60M | 72.48M |
| Net Income | -5.14M | -17.48M | -24.41M | -14.09M | -18.01M |
| EPS (Diluted) | -0.14 | -0.49 | -0.75 | -0.51 | -0.69 |
| Gross Profit | 204.37M | 150.37M | 90.55M | 63.21M | 54.26M |
| Operating Income | 36.40M | 8.82M | 431,000.0 | 1.92M | 1.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 399.48M | 388.97M | 311.76M | 157.38M | 98.33M |
| Total Liabilities | 347.39M | 319.67M | 241.75M | 130.14M | 87.40M |
| Shareholders' Equity | 52.45M | 69.65M | 70.36M | 27.60M | 11.29M |
| Total Debt | 251.98M | 228.83M | 190.50M | 112.23M | 77.96M |
| Cash & Equivalents | 72.93M | 47.25M | 74.09M | 96.27M | 42.17M |
| Current Assets | 211.75M | 189.65M | 139.07M | 118.26M | 60.66M |
| Current Liabilities | 96.30M | 91.34M | 49.34M | 18.63M | 9.72M |